SinoVac Biotech Shares Stalled
This is a news story, published by Yahoo Finance, that relates primarily to Covid news.
Covid news
For more Covid news, you can click here:
more Covid newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
corporate governance. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Sickly Corporate Governance news, biotech stocks news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
largest shareholderCorpGov
•Health
Health
Seeking a Cure for Sickly Corporate Governance at SinoVac

76% Informative
Chinese SinoVac Biotech Ltd. (Nasdaq: SVA) shares have been frozen since 2019 amid shareholder disputes.
Company developed wildly successful Covid vaccine and has over $10 billion in cash on balance sheet.
Current board is fending off a competing slate of directors supported by the founder/CEO along with large investors representing over 31% of shares outstanding.
Shareholders will decide on whether to keep or replace board at a meeting on July 8 .
The current board has eroded down to just four members after multiple departures.
Pengfei Li was sentenced to prison after charges including embezzlement and forging government documents and seals related to his attempt to seize control of a SinoVac subsidiary.
Professor Elson noted that the company has performed well with a highly successful drug and that its operations aren’t the concern at hand.
VR Score
73
Informative language
70
Neutral language
45
Article tone
formal
Language
English
Language complexity
59
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
3
Source diversity
1
Affiliate links
no affiliate links